Furthermore, the majority of MM cell lines are responsive to IL-6 treatment and consequently upregulate STAT3 phosphorylation [22] As mutations in the STAT3 gene were not observed in MM, the hyperactivation of STAT3 can be attributed to various genetic and epigenetic mechanisms. This evidence concerns the gene STAT3 and Miyoshi myopathy.